Medical plants for lung cancer: an overview of current knowledge
Immunopathologia Persa · 24.12.2022 · 9 (1) · e38455
DOI: 10.34172/ipp.2022.38455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunopathologia Persa, online erschienen am 24.12.2022. Verfasst von Mohammadreza Khosravifarsani und 8 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Lung cancer is an uncontrolled cell growth in lung tissue, with changes in the cellular, epigenetic and genetic alterations, oncogenes activation and clonal evolution of malignant cells. The most critical risk factor for lung cancer is cigarette smoking (80-85%). Other reasons for lung cancer (15-20%) include genetic factors, exposure to secondhand smoke, air pollution, radiation, hazardous gases and foreign chemical agents. The most widely used strategies in lung cancer treatment are chemotherapy, radiotherapy and surgery. However, there are various adverse effects, such as significant toxicity, limited efficiency and multidrug resistance. Plants and plant-derived products have proven to have a role in lung cancer therapy and prevention through sensitizing conventional factors, extending patient survival time, avoiding adverse effects of chemotherapy, promoting physiological improvement and ameliorating quality of life in pulmonary malignancy cases. For this review article, we searched Web of Science, EBSCO, Scopus, PubMed/Medline, DOAJ (Directory of Open Access Journals), Embase, and Google Scholar, using various keywords. There are several natural product molecules with anticancer properties through many molecular mechanisms, including, inducing apoptosis, inhibition of angiogenesis and metastasis, reversion of multidrug resistance and also targeting reactive oxygen species signaling. Some phytochemical compounds are discussed as anticancer agents for lung cancer.
Zitieren
APA
Khosravifarsani, M., Tolouian, R., Yadollahifarsani, S., Soleimani, P., Sarazen, M., Mostafizi, P., Tolouian, A., Philip, A. K., & Hotkani, Z. G. (2022). Medical plants for lung cancer: an overview of current knowledge. Immunopathologia Persa, 9(1), e38455. https://doi.org/10.34172/ipp.2022.38455
Vancouver
Khosravifarsani M, Tolouian R, Yadollahifarsani S, Soleimani P, Sarazen M, Mostafizi P, et al. Medical plants for lung cancer: an overview of current knowledge. Immunopathologia Persa. 2022;9(1):e38455. doi:10.34172/ipp.2022.38455
BibTeX
@article{Khosravifarsani2022,
author = {Khosravifarsani, Mohammadreza and Tolouian, Ramin and Yadollahifarsani, Sepideh and Soleimani, Parisa and Sarazen, Marni and Mostafizi, Pouria and Tolouian, Audrey and Philip, Anil K. and Hotkani, Zahra Golestani},
title = {Medical plants for lung cancer: an overview of current knowledge},
journal = {Immunopathologia Persa},
year = {2022},
volume = {9},
number = {1},
pages = {e38455},
doi = {10.34172/ipp.2022.38455}
}
EUVIMED